Mersana Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]